Understanding the results of MORPHO: gilteritinib as post-transplant maintenance for FLT3-ITD AML
2:03
YouTubeVJHemOnc – Video Journal of Hematology & HemOnc
Understanding the results of MORPHO: gilteritinib as post-transplant maintenance for FLT3-ITD AML
Mark Levis, MD, PhD, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, shares insights into the results of MORPHO (NCT02997202), a randomized trial of gilteritinib versus placebo as post-transplant maintenance for FLT3-ITD acute myeloid leukemia (AML) in first remission. Dr Levis highlights that the trial's negative outcome could be ...
17 views3 weeks ago
Related Products
Cancer Cell with Gilteritinib
FLT3 Gilteritinib
Venetoclax Gilteritinib Midostaurin Synergetic
#gilteritinib
The all-oral regimen of decitabine/cedazuridine, venetoclax, & gilteritinib for older pts with AML
The all-oral regimen of decitabine/cedazuridine, venetoclax, & gilteritinib for older pts with AML
YouTubeJun 16, 2024
Gilteritinib monotherapy vs combination therapy in R/R FLT3-mutated AML
Gilteritinib monotherapy vs combination therapy in R/R FLT3-mutated AML
YouTubeSep 11, 2024
Top videos
Evidence for the use of gilteritinib as post-transplant maintenance in R/R AML
1:00
Evidence for the use of gilteritinib as post-transplant maintenance in R/R AML
YouTubeVJHemOnc – Video Journal
24 views3 weeks ago
Optimizing therapy and extending survival in AML: balancing efficacy and toxicity
1:46
Optimizing therapy and extending survival in AML: balancing efficacy and toxicity
YouTubeVJHemOnc – Video Journal
82 views2 months ago
Dr Arora on Azacitidine Plus Venetoclax and Gilteritinib in FLT3 Wild-Type AML
1:09
Dr Arora on Azacitidine Plus Venetoclax and Gilteritinib in FLT3 Wild-Type AML
YouTubeOncLive
25 views2 weeks ago
Gilteritinib Side Effects
The combination of decitabine, venetoclax, and gilteritinib for treating AML in older adults
1:49
The combination of decitabine, venetoclax, and gilteritinib for treating AML in older adults
YouTubeVJHemOnc – Video Journal
18 views3 weeks ago
The VICEROY study: VEN/AZA/GILT in newly diagnosed FLT3-mutated AML
2:39
The VICEROY study: VEN/AZA/GILT in newly diagnosed FLT3-mutated AML
YouTubeVJHemOnc – Video Journal
13 views3 weeks ago
Combining targeted agents with existing backbones to improve outcomes in AML
1:41
Combining targeted agents with existing backbones to improve outcomes in AML
YouTubeVJHemOnc – Video Journal
1 views5 months ago